Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Nicholas Dillon

    Address9500 Gilman Drive #0760
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Dillon N, Peterson ND, Feaga HA, Keiler KC, Baughn AD. Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA. Sci Rep. 2017 Jul 21; 7(1):6135. PMID: 28733601.
        View in: PubMed
      2. Rosen BC, Dillon N, Peterson ND, Minato Y, Baughn AD. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017 Feb; 61(2). PMID: 27855077.
        View in: PubMed
      3. Peterson ND, Rosen BC, Dillon N, Baughn AD. Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2015 Dec; 59(12):7320-6. PMID: 26369957; PMCID: PMC4649215.
      4. Dillon N, Peterson ND, Rosen BC, Baughn AD. Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide. Antimicrob Agents Chemother. 2014 Dec; 58(12):7258-63. PMID: 25246400; PMCID: PMC4249577.
      5. Frederick RO, Bergeman L, Blommel PG, Bailey LJ, McCoy JG, Song J, Meske L, Bingman CA, Riters M, Dillon N, Kunert J, Yoon JW, Lim A, Cassidy M, Bunge J, Aceti DJ, Primm JG, Markley JL, Phillips GN, Fox BG. Small-scale, semi-automated purification of eukaryotic proteins for structure determination. J Struct Funct Genomics. 2007 Dec; 8(4):153-66. PMID: 17985212; PMCID: PMC2668602.